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MINI-REVIEW
Human Papillomavirus Genotype Distribution among Thai
Methodological Approach
Source of study identification An electronic literature search was performed through PubMed, Scopus, Google Scholar, and Thai database of health science journals (thailand.digitaljournals.org). A systematic search strategy was developed based on a preliminary scope of studies involving HPV prevalence and genotype distribution among Thai women who had high-grade cervical intraepithelial lesions and invasive cervical cancer. High-grade cervical intraepithelial lesions were defined as cervical intraepithelial neoplasia grade 2-3 (CIN 2-3) and adenocarcinoma in situ (AIS).
Search terms were formulated based on an interpretation of the population/problem of interest, intervention and context (PICO) framework (Cooke et al., 2012) . We also manually searched the reference lists of identified publications to ascertain additional relevant articles. The last update searching was performed in May, 2015.
Study selection and data extraction
We solely included studies that used PCR-based assays to identify HPV. Abstracted data included: (1) year of publication, (2) area of sample, (3) histology subtype, (4) type of specimens, (5) polymerase chain reaction (PCR) primer used, (6) overall prevalence and type-specific of HPV infection stratified by histological classification, (7) single or multiple infection, and (8) prevalence obtained from combined single and multiple infections. The authors may be contacted for more information if necessary.
Where available, invasive cervical cancer (ICC) was independently classified into squamous cell carcinoma (SCCA), adenocarcinoma (ADCA), adenosquamous carcinoma (ASCA), and neuroendocrine carcinoma (NECA). If histology-specific HPV genotype distribution was not reported, they were classified as unspecified ICC.
Review Findings
Cervical intraepithelial neoplasia grade [2] [3] In general, CIN 2-3 has been accepted as a threshold of initiating definite treatment of precancerous lesion of SCCA (Massad et al., 2013) . Identifying HPV genotype distribution in CIN 2-3 lesions that potentially progress to SCCA is utmost important in gaining insight into the oncogenic potential of the different HPV genotypes, designing protocol for screening, and estimating the efficacy of type-specific HPV vaccine. In a meta-analysis of 4338 cases with CIN 2-3, the five most common HPV genotypes in either single or multiple infections were HPV 16 (45.0%), HPV 31 (8.8%), HPV 33 (7.2%), HPV 18 (7.1%), and HPV 58 (6.9%) (Clifford et al., 2003) . In population-based study conducted in Norway to determine HPV genotype distribution in CIN 2-3 cases, multiple HPV infections were more common than infection with a single HPV type. In this study, the common HPV genotype, as single and/or in concurrence with other types included HPV 16 (51.2%), HPV 31 (16.3%), HPV 33 (15.2%), HPV 52 (11.2%), HPV 18 (10.9%), and HPV 51 (9.3%) (Sjoeborg et al., 2010) . In addition, HPV 16 and HPV 33 were associated with higher prevalence of CIN 3 suggesting a high oncogenic potential by nature of these two HPV genotypes for women in this region. The prevalence of HR-HPV infection among Thai women with CIN 2-3 ranged from 64.8% to 90.1% (Suthipintawong et al., 2011; Aromseree et al., 2014) . The three most common HR-HPV genotypes noted among Thai women with CIN 2-3 were HPV 16 (38.5%), HPV 58 (20.0%), and HPV 18 (5.5%) (Aromseree et al., 2014) . The prevalence of HPV 58 infection among Thai women with CIN 2-3 is notably high when compared to the findings in a previous meta-analysis (20.0% versus 6.9%, respectively) (Clifford et al., 2003; Aromseree et al., 2014) Table 1 shows the prevalence ratio of type-specific HPV between SCCA and CIN 2-3 which has been proposed as an indicator of potential likelihood of progression to invasive stage (Clifford et al., 2003) . In a meta-analysis conducted by Clifford et al. (2003) , HPV 45, HPV 18, and HPV 16 showed SCCA/CIN 2-3 ratios of 1.85, 1.79, and 1.21, respectively, highlighting that these HPV genotype may be more likely to progress from CIN 2-3 to SCCA than other high-risk genotypes which had SCCA/CIN 2-3 prevalence ratios between 0.10 and 0.59 (Clifford et al., 2003) .
In Thailand, data regarding type-specific HR-HPV prevalence ratio of cervical cancer and CIN 2-3 was available in only one study conducted in Northeast Thailand. HPV 18 and HPV 45 infections among Thai women showed high SCCA/CIN 2-3 prevalence ratios (3.64 and 2.79, respectively) which are consistent with trends reported in a previous meta-analysis. The interesting findings among Thai women was a considerably high SCCA/CIN 2-3 prevalence ratios observed in HPV 33 and HPV 58 infection (1.40 and 1.38, respectively), emphasizing a regional variation of HPV genotypes distribution in CIN 2-3 and the importance of HPV 33 and HPV 58 infection in the risk of progression from CIN 2-3 to invasive cancer among Thai women (Aromseree et al., 2014) . Further large scale studies are warranted to confirm these compelling results.
Adenocarcinoma in situ (AIS)
AIS has been acknowledged as pre-invasive lesion of adenocarcinoma (Zaino, 2002) . However, incidence of AIS is relatively low (Kietpeerakool et al., 2006; Srisomboon et al., 2007) . Similar to the pre-invasive lesion of cervical squamous cell carcinoma, almost all AIS lesions have evidences of HR-HPV infection. Table  2 displays the incidence and genotype distribution of HR-HPV among women with AIS. The most common HPV genotypes found in AIS lesion are HPV 16 and 18, which account for more than 90% of cases (Rabelo-Santos et al., 2009; Quint et al., 2010; Ault et al., 2011; Andersson et al., 2013) . AIS lesions infected with multiple HPV genotypes are commonly observed among young women (Andersson et al., 2013) . In the HPV vaccine trial, almost all AIS lesions (96%) were noted to be positive for HR-HPV testing but only 9.1% had glandular abnormality on concomitant cervical cytology (Ault et al., 2011) . This observation indicates the potential benefit of incorporating HR-HPV testing into cervical cytology screening to better identifying AIS. However, data regarding the prevalence and genotype distribution of HR-HPV infection in AIS specific for Thai women remain unavailable.
Invasive cervical cancer (ICC)
In the recent meta-analysis conducted by Li et al (2011) :http://dx.doi.org/10.7314/APJCP.2015.16.13.5153 HPV Genotype Distribution among Thai Women with High-Grade CIL and Invasive Cervical Cancer: a Literature Review which aimed to determine the HPV genotype distribution among 30,848 ICC worldwide, the overall prevalence of HPV in the studies published during 1990-1999 and 2006-2012 were approximately 86% and 93%, respectively. Prevalence of multiple HPV infection was noted in 11.2% of ICC specimens. Table 3 displays the distribution of HPV reported from this meta-analysis (Li et al., 2011) .
The high prevalence of HR-HPV infection among Thai women with ICC also has been consistently reported across the regions ranging from 77% to 97% (Tungsinmunkong et al., 2006; Siriaunkgul et al., 2008; Siriaunkgul et al., 2011; Chinchai et al., 2012; Natphopsuk et al., 2013; Siriaunkgul et al., 2013; Aromseree et al., 2014) . In addition, more than 60% of ICC was HPV 16 and/or 18-related supporting that the majority of ICC in all regions is associated with HPV16 and/or 18. Multiple HPV infection in Thai women varied widely from approximately 6% to 20% depending on histologic subtypes of ICC (Table 4) (Siriaunkgul et al., 2008; Siriaunkgul et al., 2011; Chinchai et al., 2012; Natphopsuk et al., 2013; Siriaunkgul et al., 2013) .
For SCCA, five most prevalent HPV types as single and multiple infection among Thai women, in order of decreasing prevalence, were HPV 16, HPV 18, HPV 58, HPV 52, and HPV 33 (Table 5 ) (Siriaunkgul et al., 2008; Natphopsuk et al., 2013; Aromseree et al., 2014) . More than 75% of SCCA were HPV 16 and/or 18-related which was comparable to the reported result of 72.5% from the meta-analysis (Li et al., 2011) . However, HPVgenotypes following HPV 16/18 observed in this meta-analysis, in descending order, were HPV 58, HPV 33, and HPV 45. Interestingly, this meta-analysis reported that the relatively high prevalence of HPV 52 and HPV 58 infection in ICC is unique for Eastern Asia. The third and fourth most common HPV infections after HPV 16 and HPV 18 in ICC specimens obtained from Eastern Asia were HPV 58 and HPV 52, respectively which was similar to the findings in Thai women (Li et al., 2011) .
Singly or in combination, five most common HPV types among Thai women with ADCA included HPV 18 (65.5%), HPV 16 (30.3%), HPV 45 (3.4%), HPV 52 (2.1%), and HPV31 (2.1%) (Table 6 ). Interestingly, the prevalence of HPV 18-related ADCA among Thai women was notably high as compared to the findings from the meta-analysis (65.5% versus 36.8%) (Li et al., 2011; Siriaunkgul et al., 2013) . Further studies are warranted to confirm this different finding.
NECA is an uncommon histological subtype of ICC accounting for approximately 1% of the cases . Data regarding prevalence and genotype distribution among women with NECA, an aggressive cell type, are limited due to its rarity. Available evidences based on only a constrained number of NECA cases demonstrate that almost all of NECA cases are associated with HPV 16 and/or HPV 18. However, in contrast to that noted in SCCA, the most prevalent HPV type among NECA cases is HPV 18, followed by HPV 16 (Masumoto et al., 2003; Ishida et al., 2004; Wang et al., 2006) . In a study from Northern Thailand which is the largest study conducted to determine HPV genotype distribution in NECA, almost 90% of cases of NECA are HPV 16 and/or HPV 18-related. Interestingly, approximately 75% of NECA were HPV18-positive when combined single and multiple infections. The next most prevalent HPV types in NECA were HPV 16 (30.1%), HPV 58 (3.2%), HPV 52 (2.1%), and HPV 33 (1.1%) (Table 6) .
Conclusion
Limited data are available for describing HPV genotype distribution in cervical cancer precursor lesions. In women with ICC, more than 60% is HPV 16 and/ or 18-related supporting that a majority of ICC in all world regions are associated with HPV16 and/or 18. Three interesting findings about the distribution of HPV genotype in ICC among Thai women have been observed including (1) a relatively high prevalence of HPV 52 and HPV 58 in SCCA; (2) the reported prevalence of HPV 18-related ADCA is almost double of incidence reported in the meta-analysis of cervical cancer worldwide, and (3) 75% of NECA are HPV18-positive when combined single and multiple infections. This review provides not only important baseline data for estimating the effectiveness of currently implemented HPV-based cervical cancer prevention but also for guiding the clinical application of newly HPV-based interventions to strengthen the public health benefits. 
